doi: 10.1016/s1359-6446(00)01594-4.
Folate-mediated targeting: from diagnostics to drug and gene delivery
Affiliations
- PMID: 11165172
- DOI: 10.1016/s1359-6446(00)01594-4
Item in Clipboard
Folate-mediated targeting: from diagnostics to drug and gene delivery
Drug Discov Today.
.
Abstract
The covalent attachment of the vitamin folic acid to almost any molecule yields a conjugate that can be endocytosed into folate receptor-bearing cells. Because folate receptors are significantly overexpressed in the majority of human cancers, this methodology is currently being investigated for the selective delivery of imaging and therapeutic agents to tumor tissue. Phase I and II clinical studies for the first folate-containing imaging agent were initiated in 1999, and clinical trials of folate-targeted therapeutic agents should soon follow. This review will summarize folate-mediated drug delivery and highlight those techniques undergoing active preclinical or clinical investigation.
Similar articles
-
Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.Acc Chem Res. 2008 Jan;41(1):120-9. doi: 10.1021/ar7000815. Epub 2007 Jul 27. Acc Chem Res. 2008. PMID: 17655275 Review.
-
Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.J Control Release. 1998 Apr 30;53(1-3):39-48. doi: 10.1016/s0168-3659(97)00236-8. J Control Release. 1998. PMID: 9741912 Review.
-
Folate-targeted non-viral DNA vectors for cancer gene therapy.Curr Opin Mol Ther. 2000 Apr;2(2):182-7. Curr Opin Mol Ther. 2000. PMID: 11249640 Review.
-
Folate-targeted chemotherapy.Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41. doi: 10.1016/j.addr.2004.01.008. Adv Drug Deliv Rev. 2004. PMID: 15094211 Review.
-
Folate-mediated targeting of therapeutic and imaging agents to cancers.Crit Rev Ther Drug Carrier Syst. 1998;15(6):587-627. Crit Rev Ther Drug Carrier Syst. 1998. PMID: 9883391 Review.
Cited by
-
Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα.Sci Rep. 2016 Aug 31;6:32427. doi: 10.1038/srep32427. Sci Rep. 2016. PMID: 27576898 Free PMC article.
-
Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1007-16. doi: 10.1007/s00259-006-0111-9. Epub 2006 Jun 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763819
-
Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates.Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):108-19. doi: 10.1007/s00259-010-1597-8. Epub 2010 Aug 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 20799032
-
18 F-click labeling and preclinical evaluation of a new 18 F-folate for PET imaging.EJNMMI Res. 2013 Sep 16;3(1):68. doi: 10.1186/2191-219X-3-68. EJNMMI Res. 2013. PMID: 24041035 Free PMC article.
-
Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy.Acta Pharm Sin B. 2019 Mar;9(2):397-409. doi: 10.1016/j.apsb.2018.11.006. Epub 2018 Nov 29. Acta Pharm Sin B. 2019. PMID: 30972285 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
